RTN4R and neoplasm: To test the effect of cyclic CNGRC on the anti-tumour activity of hPK5, mouse models of LLC and human colorectal adenocarcinoma (Colo 205) were treated with hPK5/NGR-hPK5 and hPK5/NGR-hPK5 with cisplatin.